Jenrin Discovery Inc.
Jenrin Discovery is a privately owned emerging pharmaceutical company focused on developing safer and more effective therapeutics for a variety of chronic diseases, including obesity, diabetes and autoimmune/inflammatory disorders.
The company uses a proprietary technology to develop orally effective small molecule derivatives of currently marketed drugs. This approach significantly reduces the time and investment required to take lead molecules into preclinical and clinical testing.
Jenrin’s strategy is to develop attractive licensing candidates for pharmaceutical companies, while expanding its own pipeline of “composition-of-matter” protected drugs.
